Cargando…
Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy
In recent years autophagy has attracted the attention of researchers from many medical fields, including cancer research, and certain anti-macroautophagy drugs in combination with cytotoxic or targeted therapies have entered clinical trials. In the present study, we focused on a less explored subtyp...
Autores principales: | Losmanova, Tereza, Zens, Philipp, Scherz, Amina, Schmid, Ralph A., Tschan, Mario P., Berezowska, Sabina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534862/ https://www.ncbi.nlm.nih.gov/pubmed/34685711 http://dx.doi.org/10.3390/cells10102731 |
Ejemplares similares
-
Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung
por: Losmanová, Tereza, et al.
Publicado: (2020) -
Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”
por: Losmanová, Tereza, et al.
Publicado: (2021) -
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer
por: Zens, Philipp, et al.
Publicado: (2022) -
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response
por: Zens, Philipp, et al.
Publicado: (2021) -
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases—a Single-Center Study in 190 Patients
por: Kündig, Alexandra, et al.
Publicado: (2022)